Non-alcoholic fatty liver disease: Update on treatment options and translational implications of sleep disruption
Annals of Clinical Gastroenterology and Hepatology · 2021
DOI: 10.29328/journal.acgh.1001030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical Gastroenterology and Hepatology, 2021. Verfasst von Steve M D’Souza und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Non-alcoholic fatty liver disease (NAFLD) is a condition that is associated with cirrhosis and hepatocellular carcinoma, and is increasing in prevalence worldwide. Sleep disruptions are commonly seen in NAFLD, and the disease process is associated with sleep disorders, including obstructive sleep apnea, circadian rhythm disorders, and insufficient sleep. The intermittent hypoxia seen in obstructive sleep apnea may contribute to fibrotic changes in the liver. A major component of this linkage may be related to gut microbiome changes. One notable change is increase in Bacteroidetes/Firmicutes ratio, and decrease in flora that ferment fiber into anti-inflammatory short-chain fatty acids. Several therapeutic options exist for NAFLD that target both sleep and NAFLD, including non-pharmacological factors, such as lifestyle modification (mainly diet and exercise). Pharmacological options include melatonin, Vitamin E, thiazolidinediones, and fecal microbiota transplantation.
Zitieren
APA
D’Souza, S. M., Yoo, B. S., Houston, K. V., Patel, A. J., Parekh, P. J., & Johnson, D. A. (2021). Non-alcoholic fatty liver disease: Update on treatment options and translational implications of sleep disruption. Annals of Clinical Gastroenterology and Hepatology. https://doi.org/10.29328/journal.acgh.1001030
Vancouver
D’Souza SM, Yoo BS, Houston KV, Patel AJ, Parekh PJ, Johnson DA. Non-alcoholic fatty liver disease: Update on treatment options and translational implications of sleep disruption. Annals of Clinical Gastroenterology and Hepatology. 2021. doi:10.29328/journal.acgh.1001030
BibTeX
@article{DSouza2021,
author = {D’Souza, Steve M and Yoo, Byung S and Houston, Kevin V and Patel, Ankit J and Parekh, Parth J and Johnson, David A},
title = {Non-alcoholic fatty liver disease: Update on treatment options and translational implications of sleep disruption},
journal = {Annals of Clinical Gastroenterology and Hepatology},
year = {2021},
doi = {10.29328/journal.acgh.1001030}
}
EUVIMED